Clinical Trial

Randomized Controlled Trial of the Mindful Compassion Care Program in Reducing Psychological Distress Amongst Nurses During the COVID-19 Pandemic

Study acronym: MCCP-COVID19
Recruiting
View on ClinicalTrials.gov →
Summary
Recent studies have shown that nurses have been more affected by the COVID-19 pandemic than any other group of hospital workers in terms of anxiety, depression, and burnout. Several clinical studies had previously demonstrated the effectiveness of mindfulness and compassion interventions in reducing burnout and emotional distress amongst healthcare professionals. A parallel-group randomized controlled trial will assess the feasibility, acceptability, and efficacy of a mindfulness and compassion-focused programme on frontline nurses who had been working during the COVID-19 pandemic. Seventy-two participants will be divided equally into an intervention group and a control group. Primary outcome will be assessed using the Emotional Exhaustion subscale of the Maslach Burnout Inventory General Survey (MBI-GS). Secondary outcomes will be measured by the Cynicism and Professional Efficacy subscales of the MBI-GS; the Patient Health Questionnaire (PHQ-9); the Generalized Anxiety Disorder (GAD-7); the Insomnia Severity Index (ISI); the Impact of Stressful Events (IES-R); the Perceived Stress Scale (PSS); the Five Facet Mindfulness Questionnaire (FFMQ); and the Forms of Self-Criticising/attacking and Self-Reassuring Scale (FSCRS). The study aims to fill a gap in the literature and present a scientifically validated intervention for those healthcare professionals most exposed to the stressful conditions of working during the COVID-19 pandemic.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2022-04-01; most recent amendment 2024-11-21.
Status change: Completed → Recruiting 2024-11-21
Status change: Active, Not Recruiting → Completed 2023-11-10
Status change: Not Yet Recruiting → Active, Not Recruiting 2023-02-22
Trial Details
NCT Number NCT05308537
Lead Sponsor Universita di Verona
Conditions Burnout, COVID-19
Enrollment 33 participants
Start Date 2023-01-27
Primary Completion 2023-02-19 (estimated)
Study Completion 2025-11-01 (estimated)
Updated on ClinicalTrials.gov 2024-11-25